Evidence map›Paper›PMID 26837502›Full record

ArticleFamilial cancer2016

Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies.

Masakazu Kohda, Kensuke Kumamoto, Hidetaka Eguchi, Tomoko Hirata, Yuhki Tada, Kohji Tanakaya, Kiwamu Akagi, Seiichi Takenoshita, Takeo Iwama, Hideyuki Ishida and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Masakazu KohdaDivision of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan.
Kensuke KumamotoDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kamoda, Kawagoe City, Saitama, 350-8550, Japan.
Hidetaka EguchiDivision of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan.
Tomoko HirataDivision of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan.
Yuhki TadaDivision of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan.
Kohji TanakayaDepartment of Surgery, Iwakuni Clinical Center, Yamaguchi, 740-8510, Japan.
Kiwamu AkagiDivisions of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, 362-0806, Japan.
Seiichi TakenoshitaDepartment of Organ Regulatory Surgery, Fukushima Medical University, Fukushima, 960-1295, Japan.
Takeo IwamaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kamoda, Kawagoe City, Saitama, 350-8550, Japan.
Hideyuki IshidaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kamoda, Kawagoe City, Saitama, 350-8550, Japan. 05hishi@saitama-med.ac.jp.
Yasushi OkazakiDivision of Translational Research, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan. okazaki@saitama-med.ac.jp.
Saitama Medical University · JPSocial Insurance Saitama Chuo Hospital · JPFukushima Medical University · JPIwakuni Medical Center · JPSaitama Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic testing for hereditary colorectal polyposis/cancers has become increasingly important. Therefore, the development of a timesaving diagnostic platform is indispensable for clinical practice. We designed and validated target enrichment sequencing for 20 genes implicated in familial gastrointestinal polyposis/cancers in 32 cases with previously confirmed mutations using the HaloPlex enrichment system and MiSeq. We demonstrated that HaloPlex captured the targeted regions with a high efficiency (99.66 % for covered target regions, and 99.998 % for breadth of coverage), and MiSeq achieved a high sequencing accuracy (98.6 % for the concordant rate with SNP arrays). Using this approach, we correctly identified 33/33 (100 %) confirmed alterations including SNV, small INDELs and large deletions, and insertions in APC, BMPR1A, EPCAM, MLH1, MSH2, MSH6, PMS2, and SKT11. Our approach yielded the sequences of 20 target genes in a single experiment, and correctly identified all previously known mutations. Our results indicate that our approach successfully detected a wide range of genetic variations in a short turnaround time and with a small sample size for the rapid screening of known causative gene mutations of inherited colon cancer, such as familial adenomatous polyposis, Lynch syndrome, Peutz-Jeghers syndrome, and Juvenile polyposis syndrome.

Indexed as

Germ-Line MutationAdenomatous Polyposis ColiColorectal Neoplasms, Hereditary NonpolyposisDNA Mutational AnalysisGastrointestinal NeoplasmsGene DuplicationHigh-Throughput Nucleotide SequencingHumansIntestinal PolyposisNeoplastic Syndromes, HereditaryPeutz-Jeghers SyndromeReproducibility of ResultsSequence DeletionColorectal cancerFamilial adenomatous polyposisHereditary gastrointestinal polyposisLynch syndromeMismatch repair genes

Identifiers

PMID26837502
OpenAlexW2259003573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.